Pharma Spending Rates In Japan

31 December 1997

Japanese outpatients aged 70 or older spent half their health carebudget on drugs in 1995, says a Ministry of Health and Welfare report. This is 76% higher than the figure for outpatients under 14 years old, which came to 28.4%.

For all age groups, the average spent on drugs in relation to total health care spending was 44.1%, up 1.4% on 1994. The percentages were higher for the elderly; for those up to age 69 it was 40.9%, while for those 70 or older it was 49.7%.

Outpatients were prescribed 3.32 different medicines on average, up from 3.25 in 1994. Older patients received an average of four types of medicine, compared to 3.98 in 1994. 11.2% of elderly outpatients were prescribed more than seven kinds of drugs and medicines. The tendency to overprescribe grew, raising national health spending. A Ministry spokesman said the cost of supplying drugs was increasing as more people suffered from chronic illnesses such as high blood pressure, "due to the greying of society."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight